newsfilter
← Latest News
GlobeNewswire·

Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency

NEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), ("Chiasma" or the "Company"), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve